Adriblastina RD

Corden Pharma Latina S.P.A.🇵🇭 Food and Drug Administration - Philippines

Approval Id: 7dfd805f8f32585e
Drug Approval Philippines Name: Adriblastina RD
Product Name: Adriblastina RD
Registration Number: DRP-3413
Brand Name: Adriblastina RD
Generic Name: Doxorubicin Hydrochloride
Dosage Form: Lyophilized Powder for Injection (IV)
Dosage Strength: 50 mg
Manufacturer: Corden Pharma Latina S.P.A.
Importer: Pfizer, Inc.
Company Detail Path: /organization/corden-pharma-latina-spa
Importer Detail Path: /organization/pfizer-inc-pleasant-prairie-wisconsin-united-states
Issuance Date: 09 February 2023
Expiry Date: 09 February 2028
Pharmacologic Category: Antineoplastic (Anthracycline)
Classification: Prescription Drug (RX)

Approved

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

7dfd805f8f32585e

Type

Standard